|
Market Closed -
NSE India S.E.
04:35:09 21/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 10.47 INR | +1.75% |
|
-4.82% | -46.06% |
| 15/08 | Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh | CI |
| 14/08 | Nectar Lifesciences Limited Announces Board and Committee Changes, Effective August 14, 2026 | CI |
Company Valuation: Nectar Lifesciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2,198 | 4,171 | 5,393 | 3,577 | 6,761 | 5,147 |
| Change | - | 89.8% | 29.3% | -33.68% | 89.03% | -23.88% |
| Enterprise Value (EV) 1 | 9,771 | 12,945 | 13,810 | 10,936 | 12,914 | 10,769 |
| Change | - | 32.49% | 6.68% | -20.81% | 18.08% | -16.6% |
| P/E | 6.91x | -5.69x | 21.5x | -14.8x | 137x | -4.53x |
| PBR | 0.19x | 0.39x | 0.5x | 0.34x | 0.63x | 0.54x |
| PEG | - | 0x | -0x | 0x | -1x | 0x |
| Capitalization / Revenue | 0.09x | 0.27x | 0.32x | 0.23x | 0.4x | 0.31x |
| EV / Revenue | 0.41x | 0.84x | 0.83x | 0.72x | 0.77x | 0.64x |
| EV / EBITDA | 4.44x | 11.7x | 8.71x | 20.3x | 8.41x | -41.3x |
| EV / EBIT | 6.13x | 25.9x | 13.6x | -211x | 13.9x | -12.2x |
| EV / FCF | 7.5x | 6.19x | -28.1x | 42.1x | 13.3x | -63x |
| FCF Yield | 13.3% | 16.2% | -3.56% | 2.37% | 7.52% | -1.59% |
| Dividend per Share 2 | 0.05 | - | - | - | - | - |
| Rate of return | 0.51% | - | - | - | - | - |
| EPS 2 | 1.418 | -3.27 | 1.117 | -1.08 | 0.22 | -5.07 |
| Distribution rate | 3.53% | - | - | - | - | - |
| Net sales 1 | 23,664 | 15,433 | 16,689 | 15,237 | 16,846 | 16,704 |
| EBITDA 1 | 2,201 | 1,102 | 1,586 | 539.5 | 1,536 | -260.8 |
| EBIT 1 | 1,593 | 499.9 | 1,016 | -51.73 | 928.4 | -884.7 |
| Net income 1 | 317.9 | -732.6 | 250.5 | -241.8 | 49.95 | -1,137 |
| Net Debt 1 | 7,573 | 8,774 | 8,417 | 7,359 | 6,152 | 5,623 |
| Reference price 2 | 9.80 | 18.60 | 24.05 | 15.95 | 30.15 | 22.95 |
| Nbr of stocks (in thousands) | 2,24,261 | 2,24,261 | 2,24,261 | 2,24,261 | 2,24,261 | 2,24,261 |
| Announcement Date | 14/08/20 | 24/08/21 | 24/08/22 | 11/08/23 | 14/08/24 | 26/08/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.13Cr | |
| 35.1x | 6.58x | 22.81x | 0.9% | 4.77TCr | |
| 18.6x | 2.22x | 10.04x | 1.39% | 4.03TCr | |
| 27.88x | 3.39x | 17.57x | 0.91% | 1.21TCr | |
| 26.85x | 3.84x | 15.92x | 0.6% | 1.17TCr | |
| 18.73x | 3.33x | 11.58x | 3.85% | 918.98Cr | |
| 9.03x | 2.08x | 5.42x | 4.46% | 757.14Cr | |
| 15.95x | 2.08x | 6.76x | 3.2% | 723.59Cr | |
| 28.19x | 3.68x | 17.11x | 0.16% | 683.65Cr | |
| Average | 22.54x | 3.40x | 13.40x | 1.93% | 1.58TCr | |
| Weighted average by Cap. | 25.41x | 4.04x | 15.46x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NECLIFE Stock
- Valuation Nectar Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions
